Active ingredientCevimelineCat. No. P-C124-001CAS 107233-08-9Family · Pharmaceutical analytical standards
Cevimeline
An M1 and M3 muscarinic receptor agonist that stimulates the salivary glands: approved in the United States in 2000, it is used for dry mouth in Sjögren's syndrome. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It was born in Israel as a possible 'cognition enhancer' and was studied in Alzheimer's disease, because it stimulates the M1 receptors involved in memory; only later was it used for dry mouth.
Go to the active ingredient →Active ingredientCevimelineCat. No. P-C124-001CAS 107233-08-9
Metaboliterac-Cevimeline N-Glucuronide (Mixture of Diastereomers)Cat. No. P-C124-002
Isotopically labelledrac-Cevimeline-d4 HCl (Mixture of Diastereomers)Cat. No. P-C124-003CAS 1286024-71-2
Impurity2,3'-Bi(quinuclidin-2-ylidene)-3-oneCat. No. P-C124-004CAS 71733-41-0
Impurity3-(mercaptomethyl)quinuclidin-3-olCat. No. P-C124-005CAS 107220-26-8
ImpurityCevimeline Impurity 1Cat. No. P-C124-007
ImpurityCevimeline Impurity 2Cat. No. P-C124-008CAS 1434122-43-6
ImpurityCevimeline Impurity 3Cat. No. P-C124-009
ImpurityCevimeline Impurity 4Cat. No. P-C124-010
ImpurityCevimeline Impurity 5 HydrochlorideCat. No. P-C124-011
ImpurityCevimeline Impurity 6Cat. No. P-C124-012
ImpurityCevimeline N-Oxide (Mixture of Diastereomers)Cat. No. P-C124-014CAS 391199-34-1
ImpurityCevimeline N-OxideCat. No. P-C124-015CAS 469890-14-0
Impuritycis-Cevimeline SulfoxideCat. No. P-C124-016CAS 124751-36-6
Impuritytrans-Cevimeline SulfoxideCat. No. P-C124-017CAS 124751-37-7
ImpurityCevimeline Sulfoxide 2Cat. No. P-C124-018
Active ingredientrac-Cevimeline HClCat. No. P-C124-019CAS 107220-28-0
Impurityrac-Cevimeline Hydrochloride (Mixture of Diastereomers)Cat. No. P-C124-020CAS 173553-37-2
ImpurityCevimeline Impurity 7Cat. No. P-C124-021CAS 1067880-99-2
Impuritytrans-Cevimeline HClCat. No. P-C124-022CAS 107220-29-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.